Retia Medical Wins SBIR Award From NIH
East Lansing, Michigan (August 17, 2012): Retia Medical, LLC, announced today that it has received a $151,000 Small Business Innovative Research (SBIR) Phase I award from the National Institute of Health. The funding represents an initial investment from the NIH to demonstrate the clinical performance of Retia’s breakthrough less-invasive technology to monitor cardiac output. Cardiac output monitoring is very useful in early detection of circulatory shock and for optimizing therapy to improve outcomes. Standard methods such as pulmonary artery catheter are invasive and can lead to complications, resulting in reduced usage. Successful development and demonstration of this blood flow monitor can provide crucial clinical data for improved treatment of critically ill patients.
Recent Press Releases:
- Retia Medical Expands Distribution of Argos® Cardiac Output Monitor to Western Europe with Medtronic
- Retia Medical Appoints Bruce Brandes to Strategic Advisory Board
- Retia Medical Presents First Public Results for Non-Invasive Cardiac Output Algorithm
- Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments